Similarly, CML-CNP considerably prohibited macrophage-induced inflammatory responses in vitro through deactivating NF-κB and down-regulating pro-inflammatory cytokines (IL-6 and TNF-α) (Li et al., 2019). Here, CNP is linked to chronic myelogenous leukemia, BCR-ABL1 positive.